Pilot Study Into LDN and NAD+ for Treatment of Patients With Post-COVID-19 Syndrome
Clinical trial NCT04604704 · COMPLETED
Trial details
- NCT number
- NCT04604704
- Sponsor
- AgelessRx
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-28
- Primary completion
- 2023-01-23
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.